Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Sustained Effect of First Line Sequential Therapy with Intensive Consolidation Chemotherapy and Allogeneic Hematopoietic Stem Cell Transplantation (ASCT) after Reduced Intensity Conditioning (RIC) for Patients with Acute Myeloblastic Leukemia (AML) in First Complete Remission (CR1).

Didier Blaise, MD, R. Tabrizi, MD, C. Faucher, MD, Mohamad Mohty, MD, J.O. Bay, MD, J.M. Boiron, MD, G. Marit, MD, S. Furst, MD, A.M. Stoppa, MD, A. Charbonnier, MD, T. Prebet, MD, C. Chabannon, MD, N. Vey

Blood (2006) 108 (11): 3000.

https://doi.org/10.1182/blood.V108.11.3000.3000

Published: 2006

Journal Articles

First Line Therapy with Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation for Patients with Acute Myeloblastic Leukemia in First Complete Remission.

Didier Blaise, J.M. Boiron, C. Faucher, M. Mohty, J.O. Bay, K. Bilger, G. Marit, V.J. Bardoux, V. Perreau, D. Coso, A.M. Stoppa, J.A. Gastaut, J. Reiffers, D. Maraninchi, N. Vey

Blood (2004) 104 (11): 101.

https://doi.org/10.1182/blood.V104.11.101.101

Published: 2004

Journal Articles

Response at Three Months Is a Good Predictive Factor for Newly Diagnosed Chronic Myeloid Leukemia Patients Treated by Recombinant Interferon-: Presented in part at the 38th annual meeting of the American Society of Hematology, Orlando, FL, December 6-10, 1996.

F.X. Mahon, C. Fabères, S. Pueyo, P. Cony-Makhoul, R. Salmi, J.M. Boiron, G. Marit, C. Bilhou-Nabera, A. Carrère, M. Montastruc, A. Pigneux, Ph. Bernard, J. Reiffers

Blood (1998) 92 (11): 4059–4065.

https://doi.org/10.1182/blood.V92.11.4059

Published: 1998

Journal Articles

Consolidation treatment of adult acute lymphoblastic leukemia: a prospective, randomized trial comparing allogeneic versus autologous bone marrow transplantation and testing the impact of recombinant interleukin-2 after autologous bone marrow transplantation. BGMT Group

M Attal, D Blaise, G Marit, C Payen, M Michallet, JP Vernant, C Sauvage, X Troussard, G Nedellec, J Pico

Blood (1995) 86 (4): 1619–1628.

https://doi.org/10.1182/blood.V86.4.1619.bloodjournal8641619

Published: 1995

Journal Articles

Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: a report of the French Registry on autologous transplantation in multiple myeloma

JL Harousseau, M Attal, M Divine, G Marit, V Leblond, AM Stoppa, JH Bourhis, D Caillot, M Boasson, JF Abgrall

Blood (1995) 85 (11): 3077–3085.

https://doi.org/10.1182/blood.V85.11.3077.bloodjournal85113077

Published: 1995

Journal Articles

High-dose recombinant interleukin-2 and acute myeloid leukemias in relapse

D Maraninchi, D Blaise, P Viens, M Brandely, D Olive, M Lopez, D Sainty, G Marit, AM Stoppa, J Reiffers

Blood (1991) 78 (9): 2182–2187.

https://doi.org/10.1182/blood.V78.9.2182.2182

Published: 1991

Journal Articles

Long-term marrow cultures after allogeneic bone marrow transplantation [letter; comment]

A Rice, J Reiffers, P Bernard, C Foures, F Lacombe, G Marit, A Broustet

Blood (1990) 76 (1): 266–267.

https://doi.org/10.1182/blood.V76.1.266.266

Published: 1990

NARROW

Sustained Effect of First Line Sequential Therapy with Intensive Consolidation Chemotherapy and Allogeneic Hematopoietic Stem Cell Transplantation (ASCT) after Reduced Intensity Conditioning (RIC) for Patients with Acute Myeloblastic Leukemia (AML) in First Complete Remission (CR1).

First Line Therapy with Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation for Patients with Acute Myeloblastic Leukemia in First Complete Remission.

Response at Three Months Is a Good Predictive Factor for Newly Diagnosed Chronic Myeloid Leukemia Patients Treated by Recombinant Interferon-: Presented in part at the 38th annual meeting of the American Society of Hematology, Orlando, FL, December 6-10, 1996.

Consolidation treatment of adult acute lymphoblastic leukemia: a prospective, randomized trial comparing allogeneic versus autologous bone marrow transplantation and testing the impact of recombinant interleukin-2 after autologous bone marrow transplantation. BGMT Group

Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: a report of the French Registry on autologous transplantation in multiple myeloma

High-dose recombinant interleukin-2 and acute myeloid leukemias in relapse

Long-term marrow cultures after allogeneic bone marrow transplantation [letter; comment]

Email alerts

ASH Publications

American Society of Hematology

Sustained Effect of First Line Sequential Therapy with Intensive Consolidation Chemotherapy and Allogeneic Hematopoietic Stem Cell Transplantation (ASCT) after Reduced Intensity Conditioning (RIC) for Patients with Acute Myeloblastic Leukemia (AML) in First Complete Remission (CR1).

First Line Therapy with Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation for Patients with Acute Myeloblastic Leukemia in First Complete Remission.

Response at Three Months Is a Good Predictive Factor for Newly Diagnosed Chronic Myeloid Leukemia Patients Treated by Recombinant Interferon-: Presented in part at the 38th annual meeting of the American Society of Hematology, Orlando, FL, December 6-10, 1996.

Consolidation treatment of adult acute lymphoblastic leukemia: a prospective, randomized trial comparing allogeneic versus autologous bone marrow transplantation and testing the impact of recombinant interleukin-2 after autologous bone marrow transplantation. BGMT Group

Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: a report of the French Registry on autologous transplantation in multiple myeloma

High-dose recombinant interleukin-2 and acute myeloid leukemias in relapse

Long-term marrow cultures after allogeneic bone marrow transplantation [letter; comment]

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only